Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0293 Transporter Info
Gene Name	SLC35B2
Transporter Name	Adenosine 3'-phospho 5'-phosphosulfate transporter 1
Gene ID	347734
UniProt ID	Q8TB61

Post-Translational Modification of This DT
Overview of SLC35B2 Modification Sites with Functional and Structural Information
Sequence	M D A R W W A V V V L A A F P S L G A G G E T P E A P P E S W T Q L W F F R F V V N A A G Y A S F M V P G Y L L V Q Y F R R K N Y L E T G R G L C F P L V K A C V F G N E P K A S D E V P L A P R T E A A E T T P M W Q A L K L L F C A T G L Q V S Y L T W G V L Q E R V M T R S Y G A T A T S P G E R F T D S Q F L V L M N R V L A L I V A G L S C V L C K Q P R H G A P M Y R Y S F A S L S N V L S S W C Q Y E A L K F V S F P T Q V L A K A S K V I P V M L M G K L V S R R S Y E H W E Y L T A T L I S I G V S M F L L S S G P E P R S S P A T T L S G L I L L A G Y I A F D S F T S N W Q D A L F A Y K M S S V Q M M F G V N F F S C L F T V G S L L E Q G A L L E G T R F M G R H S E F A A H A L L L S I C S A C G Q L F I F Y T I G Q F G A A V F T I I M T L R Q A F A I L L S C L L Y G H T V T V V G G L G V A V V F A A L L L R V Y A R G R L K Q R G K K A V P V E S P V Q K V
PTM type	X-Acetylation X-Malonylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	216
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC35B2 Lysine 216 has the potential to affect its expression or activity.
Malonylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	219
Experimental Method	Co-Immunoprecipitation
Detailed Description	Malonylation at SLC35B2 Lysine 219 has the potential to affect its expression or activity.
Phosphorylation
Alanine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[3]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	294
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Alanine 294 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[3]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	378
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Alanine 378 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[3]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Alanine 422 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[3]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	322
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Glycine 322 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[3]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	334
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Histidine 334 has the potential to affect its expression or activity.
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	137
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Serine 137 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	218
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Serine 218 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[3] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	427
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Serine 427 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	389
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Threonine 389 has the potential to affect its expression or activity.
Tyrosine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Tyrosine 54 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	138
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35B2 Tyrosine 138 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	73
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at SLC35B2 Cystine 73 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[12]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	80
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation (-S-Palm) at SLC35B2 Cystine 80 has the potential to affect its expression or activity.
Ubiquitination
Alanine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	167
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Alanine 167 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[14]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	323
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Alanine 323 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	338
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Alanine 338 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35B2			[14]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	411
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Alanine 411 has the potential to affect its expression or activity.
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	38
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Arginine 38 has the potential to affect its expression or activity.
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	287
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Asparagine 287 has the potential to affect its expression or activity.
Cystine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[16]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	73
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Cystine 73 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	311
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Cystine 311 has the potential to affect its expression or activity.
Glutamicacid	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	29
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glutamicacid 29 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glutamicacid 326 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	426
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glutamicacid 426 has the potential to affect its expression or activity.
Glycine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	83
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glycine 83 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	316
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glycine 316 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	327
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Glycine 327 has the potential to affect its expression or activity.
Leucine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	214
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Leucine 214 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	415
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Leucine 415 has the potential to affect its expression or activity.
Lysine	10 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[15] , [17]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	63
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 63 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	78
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 78 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	87
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 87 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	111
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 111 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	216
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 216 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	219
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 219 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	416
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 416 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	420
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 420 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 421 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	431
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Lysine 431 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	371
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Methionine 371 has the potential to affect its expression or activity.
Phenylalanine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[17]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	14
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Phenylalanine 14 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	82
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Phenylalanine 82 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	114
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Phenylalanine 114 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35B2			[14]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	367
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Phenylalanine 367 has the potential to affect its expression or activity.
Proline	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	86
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Proline 86 has the potential to affect its expression or activity.
Serine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	170
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Serine 170 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	283
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Serine 283 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	298
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Serine 298 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35B2			[13] , [15]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Serine 382 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	211
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Threonine 211 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	328
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Threonine 328 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	372
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Threonine 372 has the potential to affect its expression or activity.
Tryptophan	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	126
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Tryptophan 126 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35B2			[3] , [15]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	288
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Tryptophan 288 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[13]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	123
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Tyrosine 123 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35B2			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	315
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35B2 Valine 315 has the potential to affect its expression or activity.

References
1	Quantitative Proteomic Atlas of Ubiquitination and Acetylation in the DNA Damage Response. Mol Cell. 2015 Sep 3;59(5):867-81.
2	Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation. Mol Cell Proteomics. 2015 Nov;14(11):3056-71.
3	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
4	Deep Phosphotyrosine Proteomics by Optimization of Phosphotyrosine Enrichment and MS/MS Parameters. J Proteome Res. 2017 Feb 3;16(2):1077-1086.
5	Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
6	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
7	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
8	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
9	Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics. 2009 Jul;8(7):1751-64.
10	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
11	Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
12	MDD-Palm: Identification of protein S-palmitoylation sites with substrate motifs based on maximal dependence decomposition. PLoS One. 2017 Jun 29;12(6):e0179529.
13	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
14	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
15	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
16	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
17	A COFRADIC protocol to study protein ubiquitination. J Proteome Res. 2014 Jun 6;13(6):3107-13.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence